Multiple sclerosis
A new report has highlighted urgent gaps in MS diagnosis, symptom relief and treatment of disease progression. The Voice of the Patient report draws on nearly 3,000 survey responses and direct testimony from people affected by multiple sclerosis. Multiple sclerosis, or MS, is a long-term condition affecting the brain and spinal cord. It can cause [...]
Italy’s competition watchdog has opened a probe into Biogen over claims it tried to block access to a cheaper MS drug. The investigation concerns Biogen Italia and its US parent, Biogen, over allegations it tried to prevent rival drugmaker Sandoz from offering a cheaper multiple sclerosis treatment. Italy’s antitrust authority, AGCM, said on Wednesday, May [...]
MS patients face a higher risk of disabling relapses and faster disease progression as access to key treatments varies across the UK, new research has reveaoled. The analysis from the MS Society suggests access to high-efficacy treatments for multiple sclerosis differs significantly depending on where people live. Disease-modifying therapies, known as DMTs, are [...]
A stem cell trial is testing whether transplantation can improve outcomes for people with treatment-resistant relapsing MS. The phase 3 study is comparing autologous haematopoietic stem cell transplantation with the best available therapy for adults whose disease remains active despite previous high-efficacy disease-modifying treatments. Relapsing-remitting multiple sclerosis, or RRMS, is a form of MS where [...]
Psychoactive substances are commonly used by people with multiple sclerosis (MS )and may ease some symptoms while worsening others, a study suggests. MS is a long-term condition affecting the brain and spinal cord that can cause fatigue, pain, mobility issues and other symptoms. Psychoactive substances are drugs or products that affect the brain [...]
An AI partnership aims to find blood-based RNA patterns that could support earlier MS diagnosis and track disease progression. Decode Health and Circular Genomics will work together to analyse circular RNA, stable genetic molecules that may signal disease activity. The companies hope the approach could help doctors diagnose multiple sclerosis earlier and monitor how the [...]
The FDA has approved Ocrevus for children aged 10 and older in the US with relapsing-remitting MS (RRMS). In a clinical trial, the infusion therapy significantly reduced relapses and new or enlarging lesions in paediatric patients. As the second treatment approved for children and adolescents with relapsing-remitting MS, it offers a new option for patients, [...]
A woman with multiple sclerosis (MS) is swimming 24 miles to raise money for the therapy centre that has supported her for the last 15 years. Jayne Charles from Bilston will be taking on the challenge over 40 swims to fundraise for the Wolverhampton MS Therapy Centre, which marks its 40th anniversary this year. The [...]
Almost half, 48 per cent, of people with multiple sclerosis have been challenged for using accessible facilities such as disabled toilets, with some being shouted at, harassed or spat on, a survey has found. More than 150,000 people in the UK live with the autoimmune disease, which affects the brain and spinal cord and is [...]
People with type 2 diabetes face higher MS risk, with a review finding they are nearly 60 per cent more likely to develop the condition. The analysis did not, however, find clear evidence that MS increases the likelihood of developing diabetes. MS, or multiple sclerosis, happens when the immune system mistakenly attacks the myelin sheath, [...]
